Silence Therapeutics is a biotechnology company focused on the discovery, development, and delivery of novel RNA therapeutics for diseases with significant unmet medical needs. The company specializes in the development of RNA interference (RNAi) technology to create new generation medicines.

Angel style VC focused on climate tech 
- Check size: $100 to $700k
- Models: SaaS, HaaS and marketplaces
- Verticals: Energy, proptech and circularity
- Global: Europe, US and Latam




Silence

Proud to partner up with the BlueLayer team in their mission to transform the carbon credits market. They're building an operating system to provide carbon project developers with end to end support. The potential is infinite! 

COM:SILENCEVC

Silence Therapeutics

Analysis Not Available